CytoTools AG
XETRA:T5O
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
CytoTools AG
Total Liabilities & Equity
CytoTools AG
Total Liabilities & Equity Peer Comparison
BNTX
MOR
IMTX
BIO
FYB
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
CytoTools AG
XETRA:T5O
|
Total Liabilities & Equity
€21.3m
|
CAGR 3-Years
7%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Total Liabilities & Equity
€23B
|
CAGR 3-Years
115%
|
CAGR 5-Years
104%
|
CAGR 10-Years
N/A
|
|
|
MorphoSys AG
XETRA:MOR
|
Total Liabilities & Equity
€1.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
27%
|
CAGR 10-Years
15%
|
|
|
Immatics NV
NASDAQ:IMTX
|
Total Liabilities & Equity
€510m
|
CAGR 3-Years
26%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Biotest AG
XETRA:BIO
|
Total Liabilities & Equity
€1.4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
|
Formycon AG
XETRA:FYB
|
Total Liabilities & Equity
€890.4m
|
CAGR 3-Years
123%
|
CAGR 5-Years
86%
|
CAGR 10-Years
N/A
|
See Also
What is CytoTools AG's Total Liabilities & Equity?
Total Liabilities & Equity
21.3m
EUR
Based on the financial report for Jun 30, 2023, CytoTools AG's Total Liabilities & Equity amounts to 21.3m EUR.
What is CytoTools AG's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
12%
Over the last year, the Total Liabilities & Equity growth was -5%. The average annual Total Liabilities & Equity growth rates for CytoTools AG have been 7% over the past three years , 14% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
